The COVID-19 pandemic brought about unprecedented changes in many aspects of healthcare, including the treatment of opioid use disorder. One of the most significant changes was the relaxation of regulations around the prescription of buprenorphine, a medication approved by the FDA for treating
December 12, 2024The recent proposal by the FDA to ban the use of electric shock devices has sparked a significant debate among autism advocates and the public. This issue is especially pronounced at the Judge Rotenberg Educational Center near Boston, where such devices have been used on students. The prolonged
December 12, 2024The topic of elderly care is becoming increasingly significant as recent incidents have raised concerns about the safety and well-being of seniors in various eldercare facilities across the United States. This comprehensive analysis focuses on the safety issues in assisted living and nursing homes,
December 10, 2024The UK's healthcare regulatory framework is undergoing significant changes, with the General Medical Council (GMC) set to include Physician Associates (PAs) and Anaesthesia Associates (AAs) within its scope of regulation starting December 2024. This expansion represents a noteworthy shift in
December 5, 2024The recent decision by the Fifth Circuit Court of Appeals regarding the No Surprises Act (NSA) carries profound implications for how the Qualifying Payment Amount (QPA) is calculated. This intricate ruling touches not only the processes healthcare providers and insurers employ but also
December 2, 2024The U.S. Supreme Court's decision in June 2024 to overturn Chevron deference marks a significant shift in the landscape of health care regulation. This legal doctrine, established in 1984, allowed federal agencies to interpret ambiguous statutes enacted by Congress and develop regulations for
November 20, 2024